Outcome map · Supplement

Benign prostatic hyperplasia: what the evidence supports

3 graded interventions for benign prostatic hyperplasia, ranked by strength of evidence.

Overall grade
Grade C
Last revised
3
graded outcomes
0
references listed

Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.

3 at grade C — 3 graded rows

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

  • Stinging NettleEvidence grade C

    Modest

    Unclearmixed

  • Saw PalmettoEvidence grade C

    Trial 8–12 weeks

    Unclearmixed

  • PygeumEvidence grade C

    Modest

    Unclearmixed

What is uncertain

Read off the same rows as above. Nothing here is added that the entry does not itself record.

  • Thin evidence: Stinging Nettle (grade C); Saw Palmetto (grade C); Pygeum (grade C).

The evidence in words

The evidence map

This is the ranked evidence for benign prostatic hyperplasia: every compound in the knowledge base with a graded effect, best-supported first. Grades reflect replication and effect size, not popularity or marketing.

Best-supported

No intervention here reaches grade A or B — an honest reflection of how thin the evidence for benign prostatic hyperplasia still is.

Weaker or unproven

Stinging Nettle (grade C) — Modest · Saw Palmetto (grade C) — Trial 8–12 weeks · Pygeum (grade C) — Modest

Goes with

Entries that share this one's tags or conditions.

Sources

This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.

Last revised . A grade is this entry's reading of the evidence, not medical advice.